- Home
- VCV vs LAB Comparison
VCV vs LAB Comparison
Compare VCV & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCV
- LAB
- Stock Information
- Founded
- VCV 1993
- LAB 1999
- Country
- VCV United States
- LAB United States
- Employees
- VCV N/A
- LAB N/A
- Industry
- VCV Trusts Except Educational Religious and Charitable
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- VCV Finance
- LAB Industrials
- Exchange
- VCV Nasdaq
- LAB Nasdaq
- Market Cap
- VCV 505.7M
- LAB 534.8M
- IPO Year
- VCV N/A
- LAB 2011
- Fundamental
- Price
- VCV $10.58
- LAB $1.30
- Analyst Decision
- VCV
- LAB Buy
- Analyst Count
- VCV 0
- LAB 2
- Target Price
- VCV N/A
- LAB $2.50
- AVG Volume (30 Days)
- VCV 107.9K
- LAB 1.2M
- Earning Date
- VCV 01-01-0001
- LAB 10-29-2025
- Dividend Yield
- VCV 4.09%
- LAB N/A
- EPS Growth
- VCV N/A
- LAB N/A
- EPS
- VCV 0.13
- LAB N/A
- Revenue
- VCV N/A
- LAB $172,271,000.00
- Revenue This Year
- VCV N/A
- LAB N/A
- Revenue Next Year
- VCV N/A
- LAB N/A
- P/E Ratio
- VCV $75.82
- LAB N/A
- Revenue Growth
- VCV N/A
- LAB 76.33
- 52 Week Low
- VCV $8.05
- LAB $0.92
- 52 Week High
- VCV $10.40
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- VCV 60.58
- LAB 48.53
- Support Level
- VCV $10.49
- LAB $1.25
- Resistance Level
- VCV $10.60
- LAB $1.38
- Average True Range (ATR)
- VCV 0.09
- LAB 0.07
- MACD
- VCV 0.01
- LAB -0.00
- Stochastic Oscillator
- VCV 92.29
- LAB 26.83
About VCV Invesco California Value Municipal Income Trust
Invesco California Value Municipal Income Trust is engaged in the field of financial services. Its objective is to seek to provide common shareholders with a high level of current income exempt from federal and California income taxes, consistent with preservation of capital.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.